Leonteq AG / Key word(s): Agreement
PRESS RELEASE | LEONTEQ AND BLACKROCK TO PARTNER IN THE FUND DERIVATIVES AREA
Zurich, 30 June 2020
Leonteq AG (SIX: LEON) announced today that it is launching a strategic partnership with BlackRock to develop and distribute derivative products linked to BlackRock's fund universe.
Leonteq and BlackRock have launched a cooperation for the development, distribution and marketing of derivative products linked to BlackRock's Luxembourg mutual fund range and iShares UCITS ETF range. BlackRock is one of the leading asset managers globally. As a strategic partner, Leonteq will develop and market structured investment products with BlackRock funds and iShares ETFs as underlying assets. In addition, Leonteq will include BlackRock's range of funds and iShares as underlyings on its digital marketplace for structured products, LynQs, and generate monthly product ideas for distribution across its global salesforce.
Leonteq's fund derivatives desk provides dedicated trading and structuring expertise on mutual funds, working closely with a wide range of fund management companies to deliver innovative solutions and competitive pricing. Thanks to Leonteq's structured products expertise, it is able to offer clients downside protection, potential for higher returns or more investment flexibility when investing in mutual funds.
Lukas Ruflin, CEO at Leonteq, said: "We are proud to be partnering with BlackRock and excited that our fund derivates capabilities have convinced the largest investment manager worldwide. We look forward to presenting new investment ideas and services on fund derivatives to our global client franchise."
Ed Gordon, Head of iShares & Wealth BlackRock Switzerland, comments: "This new partnership presents a great opportunity to introduce our leading funds and ETF range to a broader group of structured product investors. We are pleased to combine our funds with Leonteq's structuring expertise to help clients fulfil their long-term financial goals."
This press release may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "target" "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the Company or any of its affiliates or subsidiaries and those explicitly or implicitly presumed in these statements. These factors include, but are not limited to: (1) general market, macroeconomic, governmental and regulatory trends, (2) movements in securities markets, exchange rates and interest rates and (3) other risks and uncertainties inherent in our business. In addition, currently, it is very difficult to provide a meaningful prediction on how the governmental actions in response to the ongoing outbreak of a novel coronavirus disease (COVID-19) and other COVID-19 related factors will affect Leonteq's operations and how long such measures will remain in place. The COVID-19 outbreak has caused, and may continue to cause, uncertainty, economic instability and a significant decrease of total economic output in the affected areas and globally. The impact of the COVID-19 outbreak on the general economic environment in the markets in which Leonteq operates remain uncertain and could be significant. Against the background of these uncertainties, you should not rely on forward-looking statements. Neither the Company nor any of its affiliates or subsidiaries or their respective bodies, executives, employees and advisers assume any responsibility to prepare or disseminate any supplement, amendment, update or revision to any of the information, opinions or forward-looking statements contained in this press release or to adapt them to any change in events, conditions or circumstances, except as required by applicable law or regulation.
End of ad hoc announcement